Found: 9
Select item for more details and to access through your institution.
Engineered soluble ACE2 receptor: Responding to change with change.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 01, doi. 10.3389/fimmu.2022.1084331
- By:
- Publication type:
- Article
Therapeutic antibodies under development for SARS-CoV-2.
- Published in:
- View (2688-268X), 2022, v. 3, n. 2, p. 1, doi. 10.1002/VIW.20200178
- By:
- Publication type:
- Article
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16048-4
- By:
- Publication type:
- Article
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12321-3
- By:
- Publication type:
- Article
Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequency.
- Published in:
- Theranostics, 2023, v. 13, n. 11, p. 3641, doi. 10.7150/thno.82144
- By:
- Publication type:
- Article
CAR Macrophages for SARS-CoV-2 Immunotherapy.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.669103
- By:
- Publication type:
- Article
The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02492-1
- By:
- Publication type:
- Article
The therapeutic potential of exosomes in immunotherapy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1424081
- By:
- Publication type:
- Article
Small extracellular vesicles purification and scale-up.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1344681
- By:
- Publication type:
- Article